| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.08 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |